Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004497 · ClinicalTrials.gov registry record · Phase 3
Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension
A Phase 3 study, sponsored by United Therapeutics.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00004497 is a Phase 3 study that has completed, run by United Therapeutics.
The verdict
NCT00004497, a Phase 3 study, has completed, sponsored by United Therapeutics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
OBJECTIVES: I. Determine the safety and efficacy of UT-15 in patients with severe symptomatic primary pulmonary hypertension.
Interventions
- DRUG UT-15
Trial Details
| Field | Value |
|---|---|
| Start Date | 1998-10 |
| Est. Completion | 2000-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004497
The ClinicalTrials.gov registry entry for NCT00004497 describes a study currently listed as completed, categorized as Phase 3. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is United Therapeutics, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which UT-15 is the first listed.
NCT00004497 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004497 about?
NCT00004497 is a clinical study titled "Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension". OBJECTIVES: I. Determine the safety and efficacy of UT-15 in patients with severe symptomatic primary pulmonary hypertension.
What is the current status of trial NCT00004497?
This trial is currently completed. It is a Phase 3 study. The study started on 1998-10. Estimated completion is 2000-09.
What interventions are being tested in trial NCT00004497?
The interventions under investigation include: UT-15 (DRUG).
Who is sponsoring clinical trial NCT00004497?
This trial is sponsored by United Therapeutics, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.